Abstract
Ameloblastoma is an odontogenic tumor of epithelial origin most commonly diagnosed in the world's oral pathology services. It has an incidence of 0.5 cases/million/year, with no gender preference and marked involvement of the posterior region of the gnathic bones, with emphasis on the mandible (80% of cases). Surgical removal consists of the treatment of choice, but it has a great impact …